Derek Hayden Oakley

Derek Hayden Oakley, M.D., Ph.D., is Assistant Professor of Pathology at Massachusetts General Hospital and Harvard Medical School. Based in the Department of Pathology, his laboratory integrates human iPSC-based neuronal models, quantitative 3-D neuropathology, and machine-learning approaches to dissect mechanisms underlying Alzheimer’s disease and related tauopathies.

Education & Training

• M.D. (Doctor of Medicine)
• Ph.D. (Doctor of Philosophy)

Research Interests

Dr Oakley’s work focuses on the molecular and cellular basis of neurodegeneration, particularly the pathobiology of tau protein and amyloid-β in Alzheimer’s disease. By leveraging patient-derived induced pluripotent stem cell (iPSC) neurons, he investigates post-translational modifications of tau and their influence on neuronal toxicity and propagation. His group also pioneers the application of machine-learning algorithms to high-resolution dissection photographs and surface scans, enabling objective, quantitative 3-D neuropathological analyses of human brain tissue.

A complementary line of research examines the intersection of innate immune signaling—such as STING activation—with neurodegeneration in ALS and frontotemporal dementia. Overall, his studies bridge fundamental mechanistic work with translational biomarker discovery, aiming to accelerate clinical trial readiness in tauopathies and synucleinopathies.

Publication Trends

Between 2020 and 2025, Dr Oakley co-authored 48 peer-reviewed papers that collectively map the molecular landscape of tau, amyloid, and innate immunity in neurodegeneration. High-impact contributions include Nature (somatic mutations in Alzheimer neurons), Acta Neuropathologica (cryptic splicing signatures of TDP-43 dysfunction), and Science Translational Medicine (cholesterol homeostasis in the living human brain). These works underscore a trajectory from mechanistic discovery towards biomarker and therapeutic target validation.

Scientific Awards & Recognition

Specific honors are not detailed in the provided text.

Research Funding & Collaborative Networks

Dr Oakley is embedded in extensive collaborative networks (>100 co-authors) anchored by Massachusetts General Hospital and the Harvard NeuroDiscovery Center. He co-leads projects with Drs Bradley Hyman and Matthew Frosch, and participates in multi-institutional consortia such as the Pick’s Disease International Consortium. His work is supported by federal and foundation grants, though exact funding details are not listed.

Laboratory & Affiliations

Laboratory location:
Massachusetts General Hospital, Pathology, WRN 245
55 Fruit Street, Boston, MA 02114, USA
Phone: +1 617-726-1077